Using Health Belief Models to understand the efficacy-effectiveness gap for mood stabilizer treatments
Using Health Belief Models to understand the efficacy-effectiveness gap for mood stabilizer treatments
复制标题
DOI：
10.1159/000068022
复制
发表时间：
2002-01-01
影响因子：
3.2
通讯作者：
Scott, Jan
中科院分区：
文献类型：
--
作者：
Scott, Jan
目的：本研究探讨了健康信念模型（HBM）在解释严重情感障碍受试者的药物依从性方面的效用。方法。使用经过验证的可靠性和有效性的完善的测量仪器来评估 98 名双相情感障碍（805 名受试者）或单相情感障碍受试者的两种 HBM 的每个组成部分以及对情绪稳定药物的依从性。结果：约 30% 的受试者符合部分依从药物治疗的标准。人口统计和诊断变量不能预测依从性状态。在预测药物依从性方面，受试者对自己的信念以及对疾病的控制比副作用更重要。自我报告的评估可预测访谈后一年入院的情况。结论：尽管该研究存在许多方法学局限性，但结果表明，对 HBM 成分进行临床评估可以改善对存在不坚持情绪稳定药物治疗风险的患者的检测。版权所有 (c) 2003 S. Karger AG，巴塞尔
Objective: This study explored the utility of Health Belief Models (HBM) in explaining medication adherence in subjects with severe affective disorders. Method. Well-established measuring instruments, with confirmed reliability and validity, were used to assess each component of two HBMs and adherence to mood-stabilising medication in 98 subjects with either bipolar (805 subjects) or unipolar disorders. Results: About 30% of subjects met criteria for partial adherence to medication. Demographic and diagnostic variables did not predict adherence status. Subjects' beliefs about themselves and their control over the disorder were more important than side-effects in predicting medication adherence. Self-reported assessments were predictive of admission to hospital in the year after the interview. Conclusion: Although the study has a number of methodological limitations, the results suggest that clinical assessment of components of HBMs may improve the detection of patients at risk of non-adherence to mood-stabilising medication. Copyright (c) 2003 S. Karger AG, Basel